Default

Allergy and immunology

Anaesthesia

Basic research

Cardiovascular medicine

Complementary medicine and alternative therapies

Critical care / intensive care

Dentistry / oral medicine

Dermatology

Emergency medicine

Endocrinology

Epidemiology

Ethics

Evidence-based medicine

Gastroenterology

Genetics

Geriatric medicine / aging

Haematology / blood transfusion

Health economics

Health policy

History of medicine

Infectious diseases

Internal medicine

Laboratory medicine

Medical education

Medical informatics

Neurology

Nursing

Nutrition and metabolism

Obstetrics and gynaecology

Occupational and environmental medicine

Oncology

Ophthalmology

Organisation of health care

Otolaryngology / head and neck surgery

Paediatrics

Palliative care

Pathology

Patient-physician relationship

Pharmacology and therapeutics

Primary care, family medicine

Psychiatry and psychotherapy

Psychosomatics

Public health

Quality of care

Radiology

Rehabilitation medicine

Renal medicine

Respiratory medicine

Rheumatology

Sexual medicine

Sports medicine

Statistics and research methods

Surgery

Transplantation

Travel medicine

Urology

Ops! No article found. Reset filter

Fiftieth anniversary of the first heart transplantation in Switzerland in the context of the worldwide history of heart transplantation

Review article: Biomedical intelligence
Wilhelm MJ, Ruschitzka F, Flammer AJ, Bettex D, Turina MI, Maisano F
Swiss Med Wkly. 2020;150:w20192

To commemorate the 50th anniversary of the first heart transplantation in ­Switzerland, on 14 April 1969, this article reviews the history of the procedure worldwide and current challenges.

Impact of an intra-abdominal cooling device during open kidney transplantation in pigs

Original article
Longchamp A, Meier RPH, Colucci N, Balaphas A, Orci LA, Nastasi A, Longchamp G, Moll S, Klauser A, Pascual M, Lazeyras F, Corpataux JM, Bühler L
Swiss Med Wkly. 2019;149:w20143

Transplantation of kidneys from deceased donors is associated with a high rate of postoperative renal dysfunction. During implantation, the kidney rewarms. This second warm ischaemia time is harmful, especially if prolonged.

Immunosuppressant therapeutic drug monitoring and trough level stabilisation after paediatric liver or kidney transplantation

Original article
Posfay-Barbe KM, Baudet H, McLin VA, Parvex P, Chehade H, Combescure C, Bonnabry P, Fonzo-Christe C
Swiss Med Wkly. 2019;149:w20156

Immunosuppressive therapy must be guided by therapeutic drug monitoring (TDM) in paediatric liver (LT) and kidney transplantation (KT) patients to prevent under- and overdosing, which have clinical consequences.

Solid cancer development in solid organ transplant recipients within the Swiss Transplant Cohort Study

Original article
Lengwiler E, Stampf S, Zippelius A, Salati E, Zaman K, Schäfer N, Schardt J, Siano M, Hofbauer G, the Swiss Transplant Cohort Study
Swiss Med Wkly. 2019;149:w20078

There is a large body of evidence indicating that 4 to 5% of solid organ transplant recipients develop a malignancy after transplantation, which corresponds to an approximately two- to four-fold elevated risk compared to the general population.

Health-related quality of life and stress-related post-transplant trajectories of lung transplant recipients: a three-year follow-up of the Swiss Transplant Cohort Study

Original article
Bleisch B, Schuurmans MM, Klaghofer R, Benden C, Seiler A, Jenewein J, Psychosocial Interest Group, Swiss Transplant Cohort Study
Swiss Med Wkly. 2019;149:w20019

Lung transplantation provides a viable option for the survival of end-stage lung diseases. Besides survival as a clinical outcome measure, health-related quality of life and psychological distress have become important study outcomes.

The immune influence of a parabiosis model on tumour-bearing mice

Original article
Feng N, Luo JM, Guo X
Swiss Med Wkly. 2018;148:w14678

The occurrence and development of cancer cells in the body is a dynamic process of interaction between the immune system and the tumour cells. Whether tumour growth is promoted or suppressed in the parabiosis model is still unclear.

Adult onset haemophagocytic lymphohistiocytosis prognosis is affected by underlying disease: analysis of a single-institution series of 174 patients

Original article
Zhang Q, Li L, Zhu L, Zhu J, Yang X, Zhou D, Zheng Y, Zhu M, Xie M, Sun J, Li X, Wu Y, Wei Z, Xie W, Ye X
Swiss Med Wkly. 2018;148:w14641

Haemophagocytic lymphohistiocytosis is a rare clinical syndrome characterised by activation of the mononuclear phagocytic system, and often leads to progressive multiple organ failure. Haemophagocytic lymphohistiocytosis is diagnosed late by most physicians.

Extended-criteria donors in lung transplantation in Switzerland: an evaluation of two adapted lung donor scores

Original article
Elmer A, Birrer M, Weiss J, Aubert JD, Benden C, Inci I, Krüger T, Soccal PM, Immer FF
Swiss Med Wkly. 2018;148:w14614

Various scoring systems aim to assess the quality of organs donated for transplantation. How well such scoring systems reflect the practice in lung transplantation in Switzerland has never been studied.

Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland

Original article
Steiner R, Kridel R, Giostra E, McKee T, Achermann R, Mueller N, Manuel O, Dickenmann M, Schuurmans MM, de Leval L, Fehr T, Tinguely M, Binet I, Cogliatti S, Haralamvieva E, Koller M, the Swiss Transplant Cohort Study (STCS), Dietrich PY
Swiss Med Wkly. 2018;148:w14596

Post-transplant lymphoproliferative disorder (PTLD) is a potentially life-threatening complication of immunosuppression and oncogenic viral infections.

Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997–2016

Original article
Passweg JR, Baldomero H, Ansari M, Baerlocher GM, Bargetzi M, Chalandon Y, Duchosal MA, Gerull S, Güngör T, Halter JP, Heim D, Hess U, Leibundgut K, Masouridi-Levrat S, Müller A, Nair G, Pabst T, Renner C, Schmidt A, Stussi G, Nicoloso de Faveri G, Schanz U, for the Swiss Blood Stem Cell Transplantation Group (SBST)
Swiss Med Wkly. 2018;148:w14589

Federal regulations in Switzerland have made it mandatory to maintain a registry including all heamatopietic stem cell transplants performed in the country.

Verpassen Sie keinen Artikel!

close